Smartlab Europe

ILC Dover takes over Grayling Industries

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Managing PFAS Regulations in Pharmaceutical Supply Chains

PFAS regulations in pharmaceutical supply chains are reshaping how critical materials are sourced, validated, and justified amid rising environmental scrutiny. Manufacturers must balance sustainability, regulatory compliance, and material performance to ensure uninterrupted delivery of safe and effective medicines.

Leveraging Global Drug Databases to Accelerate Research and Development

Accessing comprehensive global drug databases streamlines the drug development process, allowing researchers to utilize existing clinical data and regulatory benchmarks to shorten innovation cycles.

Drug Device Combination Products Driving Delivery Precision

Deep dive into the convergence of medical engineering and pharmaceutical science, focusing on how integrated delivery systems enhance dosing accuracy and patient outcomes.
- Advertisement -

ILC Dover has purchased Grayling Industries, a provider of advanced industrial packaging for pharmaceutical dry powder and liquid applications, food and chemicals.

Grayling is involved in manufacturing various brands for the asbestos abatement and remediation industry including Avail glove bags, D-Con decontamination enclosures, and Control chemicals.

The acquisition is expected to help ILC to strengthen its market-leading position in the global pharmaceutical powder containment market.

In addition, ILC’s extensive engineering, testing, and materials development competencies will allow Grayling to develop new solutions for its industrial packaging and asbestos abatement customers.

Grayling marketing manager Ben Greene said ILC ‘s expertise in materials and system level designs coupled with a relentless focus on reliability will be a real asset to the company and its customers.

Latest stories

Related stories

Managing PFAS Regulations in Pharmaceutical Supply Chains

PFAS regulations in pharmaceutical supply chains are reshaping how critical materials are sourced, validated, and justified amid rising environmental scrutiny. Manufacturers must balance sustainability, regulatory compliance, and material performance to ensure uninterrupted delivery of safe and effective medicines.

Leveraging Global Drug Databases to Accelerate Research and Development

Accessing comprehensive global drug databases streamlines the drug development process, allowing researchers to utilize existing clinical data and regulatory benchmarks to shorten innovation cycles.

Drug Device Combination Products Driving Delivery Precision

Deep dive into the convergence of medical engineering and pharmaceutical science, focusing on how integrated delivery systems enhance dosing accuracy and patient outcomes.

ACG Packaging Materials Joins WEF Global Lighthouse Network

ACG Packaging Materials has announced that its Shirwal manufacturing...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »